← FDA Drug Approvals (Drugs@FDA)
BUMETANIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ASPIRO · Approved 2025-02-27
Drug application
- FDA Application #
ANDA218746- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- BUMETANIDE
- Generic name
- BUMETANIDE
- Active ingredients
- BUMETANIDE
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Prescription
- Sponsor
- ASPIRO
- Manufacturer
- Camber Pharmaceuticals, Inc.
- First approval
- 2025-02-27
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown